Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma

Niza E, Castro-Osma JA, Posadas I, Alonso-Moreno C, Bravo I, Garzón A, Canales-Vázquez J, Ceña V, Lara-Sánchez A, Albaladejo J, Otero A.